December 01, 2022
In their final thoughts, Julie Parsons, MD, and John Brandsema, MD, share insights on the evolving and future SMA treatment landscape.
November 28, 2022
John Brandsema, MD, and Julie Parsons, MD, discuss considerations for combination SMA treatment and factors impacting SMA care pathways, such as prior authorization and multistep therapies.
November 23, 2022
Medical experts provide insights on factors impacting SMA treatment strategies.
November 21, 2022
Disease-modifying treatments are highlighted as key contributors to the optimization of SMA management.
November 17, 2022
Medical experts illustrate characteristics in the presentation of lupus nephritis.
November 14, 2022
Julie Parsons, M.D., and John Brandsema, M.D., explore economic burdens associated with SMA.
November 10, 2022
Disease-modifying agents play a significant role in treatment strategies for patients with SMA.
November 07, 2022
Julie Parsons, MD, and John Brandsema, MD, open a discussion surrounding prevalence of spinal muscular atrophy (SMA).
December 16, 2021
Early treatment helps improve the efficacy of treatment of spinal muscular atrophy, according to a comprehensive review article published earlier this month.
December 09, 2021
In this diagnostic proof-of-concept trial, an emerging imaging approach that uses a handheld laser demonstrated the ability to visualize muscle degeneration in children with SMA.